Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors. - Wikidata - awgldk - TriplyDB

Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors.

Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors.

http://www.wikidata.org/entity/Q39920086

about

Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations Epidemiology of hepatitis C in Croatia in the European context Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes Anti-hepatitis C virus seroprevalence in the working age population in Poland, 2004 to 2014 Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence.Decomposition of educational differences in life expectancy by age and causes of death among South Korean adults.Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.Identification of hidden key hepatitis C populations: an evaluation of screening practices using mixed epidemiological methods Prevalence and risk factors of Hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study.Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.Hepatitis B knowledge, perceptions and practices in the French general population: the room for improvement.Hepatitis C virus infection is not an independent risk factor for obstructive lung disease.Molecular epidemiology and clinical characteristics of hepatitis B identified through the French mandatory notification system.Cost-effectiveness of sofosbuvir in the treatment of patients with hepatitis C The undiagnosed chronically-infected HCV population in France. Implications for expanded testing recommendations in 2014 The Spatial Distribution of Hepatitis C Virus Infections and Associated Determinants--An Application of a Geographically Weighted Poisson Regression for Evidence-Based Screening Interventions in Hotspots.Simultaneous Human Immunodeficiency Virus-Hepatitis B-Hepatitis C Point-of-Care Tests Improve Outcomes in Linkage-to-Care: Results of a Randomized Control Trial in Persons Without Healthcare Coverage.Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide.Reducing Social Disparity in Liver Transplantation Utilization through Governmental Financial Support Prevalence of HBV Infection and Knowledge of Hepatitis B Among Patients Attending Primary Care Clinics in Poland.Clinical outcome of a patient cohort with acute hepatitis B Socioeconomic status in HCV infected patients - risk and prognosis.Prevalence and factors associated with hepatitis B virus infection among senior citizens in a southern brazilian city.Seroprevalence and Risk Factors for Hepatitis B in an Adult Population: The First Report from Birjand, South Khorasan, Iran.Multicountry burden of chronic hepatitis C viral infection among those aware of their diagnosis: a patient survey.Seroepidemiology of chronic hepatitis B and C in the French Caribbean Island of Guadeloupe New markers for diagnosis and management of chronic hepatitis C virus infection.Evolution of HCV incidence in drug users in France.Historical epidemiology of hepatitis C virus (HCV) in selected countries.Severe liver disease related to chronic hepatitis C virus infection in treatment-naive patients: epidemiological characteristics and associated factors at first expert centre visit, France, 2000 to 2007 and 2010 to 2014.Hepatitis B vaccination status in an at-risk adult population: long-term immunity but insufficient coverage.Occult hepatitis B virus infection in children born to HBsAg-positive mothers after neonatal passive-active immunoprophylaxis.Epidemiology update for hepatitis C virus and hepatitis B virus in end-stage renal disease in France.Hepatitis B virus in drug users in France: prevalence and vaccination history, ANRS-Coquelicot Survey 2011-2013.The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.Prevalence and risk factors of HCV infection in a metropolitan area in southern Italy: Tail of a cohort infected in past decades.2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV.Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review.

P2860

Q26784247-EA6CF1BE-29B8-40A6-8116-251B030B243E Q26795602-684928B9-59F5-471C-9279-88BE426B92A2 Q28069741-715D3DE6-0F05-4D99-8352-D7BE1228BC9E Q28079580-7C966911-EC96-4D71-BE8C-5FFB788E4C40 Q30245058-AF7F52F6-BD68-40FA-9ADB-350FCD614ACA Q33601691-2DA26225-6FF6-42E4-B786-518C3210A1FB Q33643082-1BF5C98A-1226-4E95-A719-EA123D69A814 Q33769225-C17D8A4E-E541-41F4-A5C6-419CB760D9F8 Q34137291-BBA3379B-4C42-46B4-A542-10781BF2CEB9 Q34510773-86768D63-7C80-4400-B08F-D397E5FA198B Q34572367-9018B183-A478-460C-BC39-996AA7858595 Q34677180-0F8620D3-6D08-4586-8DFB-86FC9C3B800C Q34771603-6325A3AE-B1CF-4FA8-8045-47390AB9C732 Q34998846-16085E80-5FAB-44FB-A9D0-E6FDE6792B63 Q35005494-05E7E866-EDCF-4744-966E-27D13CFC5BA6 Q35522668-0F34FD64-F9A8-47A3-9B24-4D41D4554D4F Q35593482-BCA85D67-448C-4E20-9EAE-BDB1B42E6A67 Q35767961-A7F7FA5B-0D35-4654-923F-F4EE162C444A Q36365938-DE252C15-D783-4F2B-91A5-DF0397546944 Q36454765-E902752A-E8F6-4280-AA7F-2F278931DF52 Q36514741-3553449D-BFE1-49E9-B902-130D2F87523B Q36828732-91E02616-8DBB-4AD9-93F2-FD85776DAE64 Q36844902-2B9A958C-29BF-40D5-8617-E484DC72FD01 Q36918975-0F019FC4-CA00-4BE4-B20C-C63FFDAFA744 Q37073859-19D991BA-63C5-4F1C-8E13-1341D8682F61 Q37387188-1BEBB5F3-962E-44CC-90CE-FD414C59D407 Q37500066-AA0CE6AF-5336-432C-878B-697FE030A9A6 Q37538871-30F74E1F-591A-4727-864B-7E484AA36422 Q37649337-1D2477B6-2324-4D64-AD41-2BBEC88655B2 Q37854914-22A1A9BB-1701-4352-9B04-72A488F966EA Q38203033-8DFD0D53-446A-4EA1-B8B3-FC2474EDFE68 Q38630130-791023C1-7F42-44A5-848F-F4C4E0FE49FA Q38912896-2C9CD0D5-F2CD-4184-A4A4-070718F4EF3C Q39006952-89D65A8D-A1EE-41AF-A303-E6E293B8ED93 Q39009606-8DB8C67D-4DE8-41CC-B598-E309ADADDEAF Q39014009-BB65691C-4028-4FB3-80B0-2780DEF4EF49 Q39213684-1C817FBA-AF3E-4689-B587-322BB6059C2F Q39269495-8787ACF1-3A98-46FC-8A58-5D763FA8D898 Q39864556-32ED57DA-A3B2-4866-9254-70F51F0EF37B Q40048159-C8B99004-1915-4894-926F-C8A8E32C4B84

P2860

Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors.

http://www.wikidata.org/entity/Q39920086

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Prevalence of hepatitis B and ...... usting for known risk factors.

@en

Prevalence of hepatitis B and ...... usting for known risk factors.

@nl

type

label

Prevalence of hepatitis B and ...... usting for known risk factors.

@en

Prevalence of hepatitis B and ...... usting for known risk factors.

@nl

prefLabel

Prevalence of hepatitis B and ...... usting for known risk factors.

@en

Prevalence of hepatitis B and ...... usting for known risk factors.

@nl

P1433

Q39920086-3E4DC82B-B946-42B2-96C7-3C31836FA519

P1476

Q39920086-3358648F-D746-4512-AB0F-934C40006129

P2093

Q39920086-2D99B219-848F-4477-9187-C264E36F7853

Q39920086-30190FCD-1AE3-4FC3-ADFF-EB9138BF49E0

Q39920086-65CC462D-275B-4792-AF06-D90DC85358D7

Q39920086-762B0E63-E905-43DC-B90A-F9AB6D4CC487

Q39920086-8C49D515-14FD-4C7E-A5E2-3A4E7CC71D59

Q39920086-9020BFBB-A68D-4619-A5B1-DC4E7AD9B7AF

Q39920086-9A10E88E-D08A-40C9-994D-9E83869162F0

Q39920086-9E4758E4-41A9-4DE8-A52D-6361255EA4E5

Q39920086-B3A7675E-3356-44F2-832D-DF871BA406B2

Q39920086-E8B11193-0F63-42E9-99F4-BCAEAC22AB13

P2860

Q39920086-02BC0081-974C-4F33-81A4-2E8297296633

Q39920086-135C3541-7CBA-412B-B706-9FCB5AE41E54

Q39920086-3B62CC19-03A3-40E6-A116-5249DD60557B

Q39920086-3DE6B74A-F700-4D7A-83FB-C448E405B446

Q39920086-454BC686-5F75-4D24-A455-40ADD24F6524

Q39920086-48DB8FE2-5B44-4FB0-9E3A-63044AF2AE71

Q39920086-51039B16-A50F-40E7-8841-B8FDCA39B242

Q39920086-55F6E759-FF3A-408E-9AC2-24548F17E396

Q39920086-6750AFFB-986D-477F-AA4F-93E50EE4A162

Q39920086-77D878BF-34DF-4253-A2E6-2444E8DE7784

P304

Q39920086-5C9CEF70-599C-4ED5-993C-369BBE5C0B95

P31

Q39920086-BF50E35F-7FF3-4F4B-A251-ED1B211555C2

P356

Q39920086-67A83BA5-983E-4751-975C-8390EEABAA6A

P433

Q39920086-EBF41AAA-1506-442F-BA55-2A478984526D

P478

Q39920086-70828125-5D5B-4777-B0F4-CF51EFB17CB2

P50

Q39920086-538C60DB-3CE3-432B-900A-FB3EE91B60A8

Q39920086-638C1BF9-37E4-4F5A-A213-8B7F9685AD08

Q39920086-BA6CCDD4-6CE0-4640-B877-21F2D10FA113

P577

Q39920086-0968D1EE-43C1-4E8F-9390-0E3247871F56

P698

Q39920086-DFA64002-74F2-4A83-A175-998E34C5CC40

P356

P1433

Journal of Medical Virology

P1476

Prevalence of hepatitis B and ...... justing for known risk factors

@en

P2093

Christine Meffre

http://www.w3.org/2001/XMLSchema#string

Denise Antona

http://www.w3.org/2001/XMLSchema#string

Dominique Coste

http://www.w3.org/2001/XMLSchema#string

Fréderic Dubois

http://www.w3.org/2001/XMLSchema#string

Jean-François Meyer

http://www.w3.org/2001/XMLSchema#string

Jean-Marie Lemasson

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Giordanella

http://www.w3.org/2001/XMLSchema#string

Josiane Steinmetz

http://www.w3.org/2001/XMLSchema#string

Josiane Warszawski

http://www.w3.org/2001/XMLSchema#string

René Gueguen

http://www.w3.org/2001/XMLSchema#string

P2860

Global epidemiology of hepatitis C virus infection

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design.

Investigating non-response bias in mail surveys.

Chronic hepatitis B.

Epidemiology of hepatitis B in Europe and worldwide.

Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000.

Viral hepatitis and HIV coinfection.

HCV-related morbidity in a rural community of Egypt.

Intrafamilial transmission of hepatitis C in Egypt.

P304

546-555

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JMV.21734

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P50

Elisabeth Delarocque-Astagneau

Jean-Claude Desenclos

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20166185

http://www.w3.org/2001/XMLSchema#string